Jinfeng Cai

Jinfeng Cai

Auto-generated profile, based on publicly available information

Jinfeng Cai

Institute of Human Virology, Key Laboratory of Tropical Disease Control of Ministry of Education, Zhongshan School of Medicine of Sun Yat-sen University

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 May 2023 in Phytomedicine
Verified
Journal Article
Closed access
HZHaitao Zhang
Haitao Zhang
JCJinfeng Cai
Jinfeng Cai
CLChunna Li
Chunna Li
LDLisi Deng
Lisi Deng
HZHongqiong Zhu
Hongqiong Zhu
JXJinyu Xia
Jinyu Xia

9 April 2021 in eLife
Verified
Journal Article
Open access
JCJinfeng Cai
Jinfeng Cai
HGHongbo Gao
Hongbo Gao
JZJiacong Zhao
Jiacong Zhao
SHShujing Hu
Shujing Hu
XLXinyu Liang
Xinyu Liang
KDKai Deng
Kai Deng
The major barrier to curing HIV-1 infection is a small pool of latently infected cells that harbor replication-competent viruses, which are widely considered the origin of viral rebound when antiretroviral therapy (ART) is interrupted. The difficulty in distinguishing latently infected cells from the vast majority of uninfected cells has represented a significant bottleneck precluding comprehensive understandings of HIV-1 latency. Here we reported and validated a newly designed dual fluorescent reporter virus, DFV-B, infection with which primary CD4+ T cells can directly label latently infected cells and generate a latency model that was highly physiological relevant. Applying DFV-B infection in Jurkat T cells, we generated a stable cell line model of HIV-1 latency with diverse viral integration sites. High-throughput compound screening with this model identified ACY-1215 as a potent latency reversing agent, which could be verified in other cell models and in primary CD4+ T cells from ART-suppressed individuals ex vivo. In summary, we have generated a meaningful and feasible model to directly study latently infected cells, which could open up new avenues to explore the critical events of HIV-1 latency and become a valuable tool for the research of AIDS functional cure.

15 June 2023 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
THTing Huang
Ting Huang
JCJinfeng Cai
Jinfeng Cai
PWPeipei Wang
Peipei Wang
JZJiasheng Zhou
Jiasheng Zhou
HZHaitao Zhang
Haitao Zhang
KDKai Deng
Kai Deng
Although antiretroviral therapy (ART) is effective in suppressing viral replication, it does not cure HIV-1 infection due to the presence of the viral latent reservoir. Rather than reactivating the latent viruses, the “block and lock” strategy aims to shift the viral reservoir to a deeper state of transcriptional silencing, thus preventing viral rebound after ART interruption.

8 August 2023 in Environmental Pollution
Verified
Journal Article
Closed access
AFAliya Fazal
Aliya Fazal
ZWZhongling Wen
Zhongling Wen
MYMinkai Yang
Minkai Yang
CWChangyi Wang
Changyi Wang
CHChenyu Hao
Chenyu Hao
Yonghua YangYonghua Yang
Yonghua Yang

26 April 2024 in Virology Journal
Verified
Journal Article
Open access
PDF file
PWPeipei Wang
Peipei Wang
ZMZhuoyue Meng
Zhuoyue Meng
KDKai Deng
Kai Deng
ZGZhi-Liang Gao
Zhi-Liang Gao
JCJinfeng Cai
Jinfeng Cai
Background: Despite the existence of available therapeutic interventions for HIV-1, this virus remains a significant global threat, leading to substantial morbidity and mortality. Within HIV-1-infected cells, the accessory viral protein r (Vpr) exerts control over diverse biological processes, including cell cycle progression, DNA repair, and apoptosis. The regulation of gene expression through DNA methylation plays a crucial role in physiological processes, exerting its influence without altering the underlying DNA sequence. However, a thorough examination of the impact of Vpr on DNA methylation in human CD4 + T cells has not been conducted. Methods: In this study, we employed base-resolution whole-genome bisulfite sequencing (WGBS), real-time quantitative RCR and western blot to explore the effect of Vpr on DNA methylation of host cells under HIV-1 infection. Results: We observed that HIV-1 infection leads to elevated levels of global DNA methylation in primary CD4 + T cells. Specifically, Vpr induces significant modifications in DNA methylation patterns, particularly affecting regions within promoters and gene bodies. These alterations notably influence genes related to immune-related pathways and olfactory receptor activity. Moreover, Vpr demonstrates a distinct ability to diminish the levels of methylation in histone genes. Conclusions: These findings emphasize the significant involvement of Vpr in regulating transcription through the modulation of DNA methylation patterns. Together, the results of this investigation will considerably enhance our understanding of the influence of HIV-1 Vpr on the DNA methylation of host cells, offer potential avenues for the development of more effective treatments.

3 June 2026 in Science Translational Medicine
Verified
Journal Article
Closed access
JCJinfeng Cai
Jinfeng Cai
WDWei Dong
Wei Dong
PWPeipei Wang
Peipei Wang
JZJiacong Zhao
Jiacong Zhao
XLXinyu Liang
Xinyu Liang
KDKai Deng
Kai Deng
As the primary receptor for HIV-1 entry, human CD4 is widely recognized as the hallmark of HIV-1 target cells. However, viral negative factor (Nef) and viral protein U (Vpu) down-regulate surface CD4 on infected cells, raising an intriguing question: If an infected CD4 + T cell survives and establishes latency, can CD4 expression recover? By tracking the fate of HIV-1–infected CD4 + T cells, we unexpectedly found that a subset of these cells directly convert to CD8 + T cells. T cell receptor (TCR) sequencing and single-cell RNA sequencing data revealed that these induced CD8 + T cells primarily originated from regulatory CD4 + T cells, which retained a regulatory-like phenotype postconversion. Mechanistically, HIV-1 viral protein R (Vpr) specifically induced this conversion by up-regulating transforming growth factor–β1 (TGF-β1), which, in turn, activates a TGF-β–dependent signaling pathway essential for CD8 lineage reprogramming. Critically, ex vivo analyses confirmed that CD8 + T cells from both untreated and antiretroviral therapy (ART)–suppressed people living with HIV-1 (PLWH) harbor transcriptionally active viral RNA or intact proviral DNA. Furthermore, we identified that human leukocyte antigen (HLA) class II–restricted CD8 + T cells, which were present in PLWH but absent in healthy controls, share TCR clonotypes with their antigen-specific CD4 + T cell counterparts, providing direct evidence for HIV-1–driven CD4-to-CD8 conversion in vivo. Collectively, these findings uncover a viral mechanism of host-cell reprogramming, demonstrate that CD8 + T cells constitute a previously overlooked component of the HIV-1 reservoir, and broaden our understanding of latent reservoir heterogeneity, an essential consideration for future cure strategies.